BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28330821)

  • 1. Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
    Choi YY; Cheong JH
    Eur J Surg Oncol; 2017 May; 43(5):856-864. PubMed ID: 28330821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From standard to new genome-based therapy of gastric cancer.
    Lianos GD; Mangano A; Cho WC; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1023-6. PubMed ID: 26108988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic options opened by the molecular classification of gastric cancer.
    Chivu-Economescu M; Matei L; Necula LG; Dragu DL; Bleotu C; Diaconu CC
    World J Gastroenterol; 2018 May; 24(18):1942-1961. PubMed ID: 29760539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine.
    Choi YY; Noh SH; Cheong JH
    Yonsei Med J; 2015 Sep; 56(5):1177-85. PubMed ID: 26256958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dawn of precision medicine on gastric cancer.
    Ishii T; Kawazoe A; Shitara K
    Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritizing therapeutic targets using patient-derived xenograft models.
    Lodhia KA; Hadley AM; Haluska P; Scott CL
    Biochim Biophys Acta; 2015 Apr; 1855(2):223-34. PubMed ID: 25783201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-induced drug resistance in gastric cancer.
    Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
    Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
    Yuen ST; Leung SY
    Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastric carcinoma: an evolutionary scenario.].
    Gelsomino F; Spallanzani A; De Vita F; Di Bartolomeo M; Gavazzi C; Rimassa L; Cascinu S
    Recenti Prog Med; 2017 Mar; 108(3):120-127. PubMed ID: 28398405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards curative therapy in gastric cancer: Faraway, so close!
    Cravo M; Fidalgo C; Garrido R; Rodrigues T; Luz G; Palmela C; Santos M; Lopes F; Maio R
    World J Gastroenterol; 2015 Nov; 21(41):11609-20. PubMed ID: 26556990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Derived Xenograft Models for Endometrial Cancer Research.
    Moiola CP; Lopez-Gil C; Cabrera S; Garcia A; Van Nyen T; Annibali D; Fonnes T; Vidal A; Villanueva A; Matias-Guiu X; Krakstad C; Amant F; Gil-Moreno A; Colas E
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
    Sun S; Zhang Z
    Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinical implementations of ovarian cancer mouse avatar models.
    Zayed AA; Mandrekar SJ; Haluska P
    Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into next developments in advanced gastric cancer.
    Obermannová R; Lordick F
    Curr Opin Oncol; 2016 Jul; 28(4):367-75. PubMed ID: 27092990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular classification of gastric cancer.
    Röcken C
    Expert Rev Mol Diagn; 2017 Mar; 17(3):293-301. PubMed ID: 28118758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug sensitivity testing platforms for gastric cancer diagnostics.
    Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
    J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The journey of personalizing gastric cancer treatment.
    Yan L
    Chin J Cancer; 2016 Aug; 35(1):84. PubMed ID: 27581614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long and short noncoding RNAs in lung cancer precision medicine: Opportunities and challenges.
    Tian H; Zhou C; Yang J; Li J; Gong Z
    Tumour Biol; 2017 Apr; 39(4):1010428317697578. PubMed ID: 28381159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.